期刊文献+

柱切换HPLC法测定人血浆中的枸橼酸 被引量:2

Determination of citric acid in the human plasma by column-switch HPLC
原文传递
导出
摘要 目的采用柱切换HPLC法测定血浆中的枸橼酸。方法预处理柱为Ultimate CN,分析柱为YMC C18,流动相为0.05mol·L^-1KH2PO4(磷酸调p H2.85),流速1 m L·min-1,检测波长210 nm。血浆样品经过酸化,超滤后进样。结果枸橼酸的线性范围为62.5-1250μg·m L^-1,方法回收率为97.41%-102.52%,批内RSD为3.52%-5.21%,批间RSD为3.07%-4.55%。结论所用方法操作简单,结果准确,重复性好,可用于血浆中枸橼酸的测定。 OBJECTIVE To develop an HPLC method for determination of citric acid in human plasma. METHODS The HPLC system consisted of pretreatment column Ultimate CN and analytical column YMC C1s-The mobile phase was 0.05 mol ·L^-1 KH2PO4 (pH 2.85) with a flow rate of 1 mL.min -1. The detection wavelength was set at 210 nm. The samples were ultrafiltrated after acidified. RESULTS The calibration curves had good linearity within the concentration range of 62.5 - 1250 μg· mL^-1. The average method recoveries for citric acid plasma concentrations were 97.41% - 102.52%. The intra - day RSD and inter - day RSD were 3.52% - 5.21% and 3.07% -4.55%, respectively. CONCLUSION This method provides a sensitive, accurate, precise and reliable analyti- cal procedure for clinical monitoring of citric acid in human plasma.
出处 《华西药学杂志》 CAS CSCD 2015年第2期232-233,共2页 West China Journal of Pharmaceutical Sciences
关键词 枸橼酸 柱切换高效液相色谱法 血药浓度 抗凝 预处理 Citric acid Column - switch HPLC Plasma concentration Anticoagulation Pretreatment
  • 相关文献

参考文献5

二级参考文献29

  • 1李文峰,张士青,顾欣.微量尿草酸测量的3种比色法比较[J].中国实验诊断学,2006,10(8):909-911. 被引量:12
  • 2吴义启,陈志强,叶章群.血草酸浓度测定的研究状况[J].现代泌尿外科杂志,2007,12(3):205-206. 被引量:6
  • 3Dean JA. Lange's handbook of chemistry, ed 15th. McGraw-Hill, 1999, Tab8,13.
  • 4Fukuda T, Nakashima Y, Harada M, et al. Effect of whole blood clotting time in rats with ionized hypocaleemia induced by rapid intravenous citrate infusion, J-Toxicol-Sci, 2006, 31 (3): 229 - 234.
  • 5James MF, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography, J-Cardiothorac-Vasc-Anesth, 2004, 18 (5) : 581 - 586.
  • 6Joannidis M. Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care, 2007,11 (4) :218.
  • 7Bunker JP, Bendixen HH, Murphy AJ. Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med, 1962,266: 372 - 377.
  • 8Bolan CD, Cecco SA, Wesley RA, et al. Controlled study of citrate effects and response to i. V. Calcium administration during allogeneie peripheral blood progenitor cell donation. Transfusion, 2002,42 (7) : 935 - 946.
  • 9Bolan CD, Greet SE, Cecco SA, et al. Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion, 2001,41 (9) : 1165 - 1171.
  • 10Bauer E, Derfler K, Joukhadar C, et al. Citrate kinetics in patients receiving long-term hemodialysis therapy. Am J Kidney Dis, 2005,46 (5) :903 - 907.

共引文献49

同被引文献29

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部